Roivant Sciences (ROIV) PT Raised to $18 at H.C. Wainwright, 'brepocitinib has blockbuster potential'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| (NASDAQ: ROIV) | Delayed: 38.46 +2.42 (6.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $36.04 | 52 Week High | $ | |||
| Open | $36.62 | 52 Week Low | $ | |||
| Day High | $38.52 | P/E | N/A | |||
| Day Low | $35.71 | EPS | $ | |||
| Volume | 5,672,956 | |||||
